CORRELATION BETWEEN COVID-19 SEVERITY AND NONINVASIVE ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD)

被引：0
作者：
Tungtrongchitr, Nuttapat
Srivanitchapoom, Nantaporn
Hirunpat, Pornrujee
Sungkanuparph, Somnuek
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
MAFLD; COVID-19; fibrosis; 8; score; 4; non-alcoholic fatty liver disease fibrosis score;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1509
引用
收藏
页码：S1394 / S1395
页数：2
相关论文
共 50 条
  • [41] Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?
    Ferron, Pierre-Jean
    Gicquel, Thomas
    Megarbane, Bruno
    Clement, Bruno
    Fromenty, Bernard
    BIOCHIMIE, 2020, 179 : 266 - 274
  • [42] The Efficacy of Tofogliflozin on Metabolic Dysfunction-Associated Fatty Liver Disease
    Goya, Takeshi
    Imoto, Koji
    Tashiro, Shigeki
    Aoyagi, Tomomi
    Takahashi, Motoi
    Kurokawa, Miho
    Suzuki, Hideo
    Tanaka, Masatake
    Kato, Masaki
    Kohjima, Motoyuki
    Ogawa, Yoshihiro
    GASTROENTEROLOGY INSIGHTS, 2022, 13 (01) : 20 - 26
  • [43] From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
    Flisiak-Jackiewicz, Marta
    Bobrus-Chociej, Anna
    Wasilewska, Natalia
    Lebensztejn, Dariusz Marek
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (05) : 1 - 11
  • [44] Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
    Zheng, Kenneth I.
    Gao, Feng
    Wang, Xiao-Bo
    Sun, Qing-Feng
    Pan, Ke-Hua
    Wang, Ting-Yao
    Chen, Yong-Ping
    Liu, Wen-Yue
    George, Jacob
    Zheng, Ming-Hua
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 108 : 154244
  • [45] Lifestyle determinants as predictor of severity of metabolic associated fatty liver disease (MAFLD)
    Attia, Abeer
    Labib, Nargis Albert
    Abdelzaher, Noha Essameldin Elsayed
    Musa, Sherief
    Atef, Mira
    EGYPTIAN LIVER JOURNAL, 2023, 13 (01)
  • [46] FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
    Gu, Zhan
    Bi, Yan
    Yuan, Fan
    Wang, Ruirui
    Li, Dong
    Wang, Jianying
    Hu, Xiaojuan
    He, Guang
    Zhang, Lei
    Liu, Bao-cheng
    CLINICAL INTERVENTIONS IN AGING, 2020, 15 : 1333 - 1341
  • [47] Therapeutic developments in metabolic dysfunction-associated fatty liver disease
    Shi, Yiwen
    Fan, Jiangao
    CHINESE MEDICAL JOURNAL, 2022, 135 (09) : 1009 - 1018
  • [48] The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
    Barrera, Francisco
    Uribe, Javier
    Olvares, Nixa
    Huerta, Paula
    Cabrera, Daniel
    Romero-Gomez, Manuel
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [49] Lifestyle determinants as predictor of severity of metabolic associated fatty liver disease (MAFLD)
    Abeer Attia
    Nargis Albert Labib
    Noha Essameldin Elsayed Abdelzaher
    Sherief Musa
    Mira Atef
    Egyptian Liver Journal, 13
  • [50] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Wang, Ting-Yao
    Wang, Rui-Fang
    Bu, Zhi-Ying
    Targher, Giovanni
    Byrne, Christopher D.
    Sun, Dan-Qin
    Zheng, Ming-Hua
    NATURE REVIEWS NEPHROLOGY, 2022, 18 (04) : 259 - 268
12345